Enhancement of cellular adenosine triphosphate levels in PC12 cells by extracellular adenosine

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 3, 2002, Pages 307-311

  Fujimori, Hiroyuki ^a   Yasuda, Masahiro ^a   Pan Hou, Hidemitsu ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Adenosine; ATP synthesis; P1 receptor; PC12 cell; Salvage pathway

Indexed keywords

5' IODOTUBERCIDIN; ADENOSINE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE DIPHOSPHATE; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE TRIPHOSPHATE; COFORMYCIN; CYTOSINE; DIPYRIDAMOLE; GLUCOSE; GUANOSINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE; THEOPHYLLINE; THYMIDINE; UNCLASSIFIED DRUG; URIDINE; 5 IODOTUBERCIDIN; 5-IODOTUBERCIDIN; ADENOSINE RECEPTOR; DRUG DERIVATIVE; TUBERCIDIN;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL LEVEL; CELL STRAIN; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; NONHUMAN; RAT; ANIMAL; METABOLISM;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; COFORMYCIN; DIPYRIDAMOLE; PC12 CELLS; RATS; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; TUBERCIDIN;

EID: 0036519278     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.307     Document Type: Article

References (32)

1. Abbracchio M. P., Burnstock G., Jpn. J. Pharmacol., 78, 113-145 (1998).
2. Ralevic V., Burnstock G., Pharmacol. Rev., 50, 413-492 (1998).
3. Gordon J. L., Biochem. J., 233, 309-319 (1986).
4. Roskoski R., Jr., Roskoski L. M., J. Neurochem., 53, 1934-1940 (1989).
5. Inoue K., Watano T., Koizumi S., Nakazawa K., Burnstock G., Eur. J. Pharmacol., 268, 223-229 (1994).
6. Kobayashi S., Conforti L., Pun R. Y. K., Millhorn D. E., J. Physiol. (London), 508, 95-107 (1998).
7. De Souza L. R., Moore H., Raha S., Reed J. K., J. Neurosci. Res., 41, 753-763 (1995).
8. Cheng Y., Chen M., James-Kracke M., Wixon P., Sun A. Y., Neurochem. Res., 21, 27-33 (1996).
9. Yakushi Y., Watanabe A., Murayama T., Nomura Y., Eur. J. Pharmacol., 314, 243-248 (1996).
10. Chen Y., Sun A. Y., Neurochem. Res., 23, 543-550 (1998).
11. Swanson K. D., Reigh C., Landreth G. E., J. Biol. Chem., 273, 19965-19971 (1998).
12. Erny R., Wagner J. A., Proc. Natl. Acad. Sci. U.S.A., 81, 4974-4978 (1984).
13. Ziganshin A. U., Hoyle C. H. V., Burnstock G., Drug Dev. Res., 32, 134-146 (1994).
14. Zimmermann H., Trends Neurosci., 17, 420-426 (1994).
15. De Souza L. R., Reed J. K., Neurochem. Int., 19, 581-592 (1991).
16. Heilbronn A., Krapohl A., Zimmermann H., Cell Tissue Res., 280, 123-131 (1995).
17. Fujimori H., Yamauchi M., Pan-Hou H., Chem. Express, 6, 715-718 (1991).
18. Fujimori H., Sasaki T., Hibi K., Senda M., Yoshioka M., J. Chromatogr., 528, 305-314 (1990).
19. Miras-Portugal M. T., Torres M., Rotllan P., Aunis D., J. Biol. Chem., 261, 1712-1719 (1986).
20. Marrone T. J., Straatsma T. P., Briggs J. M., Wilson D. K., Quiocho F. A., McCammon J. A., J. Med. Chem., 39, 277-284 (1996).
21. Kowaluk E. A., Bhagwat S. S., Jarvis M. F., Curr. Pharmaceut. Design, 4, 403-416 (1998).
22. Hide I., Padgett W. L., Jacobson K. A., Daly J. W., Mol. Pharmacol., 41, 352-359 (1992).
23. Arslan G., Kull B., Fredholm B. B., Naunyn-Schmiedeberg Arch. Pharmacol., 359, 28-32 (1999).
24. Chern Y., Lai H., Fong J. C., Liang Y. U., Mol. Pharmacol., 44, 950-958 (1993).
25. Van der Ploeg I., Ahlberg S., Parkinson F. E., Olsson R. A., Fredholm B. B., Naunyn-Schmiedeberg Arch. Pharmacol., 353, 250-260 (1996).
26. Griffith D. A., Jarvis S. M., Biochim. Biophys. Acta, 1286, 153-181 (1996).
27. Kobayashi S., Zimmermann H., Millhorn D. E., J. Neurochem., 74, 621-632 (2000).
28. Florio C., Frausin F., Vertua R., Gaion R. M., Biochem. Pharmacol., 57, 355-364 (1999).
29. Rebois R. V., Reynolds E. E., Toll L., Howard B. D., Biochemistry, 19, 1240-1248 (1980).
30. Lin Y. Y., Cheng W. B., Wright C. E., Anal. Biochem., 209, 267-273 (1993).
31. Pereira C., Santos M. S., Oliveira C., J. Neurosci. Res., 51, 360-370 (1998).
32. Bitler C. M., Howard B. D., J. Neurochem., 47, 107-112 (1986).